Valuation: CEREP

Market Cap 82.22M 96.01M 76.88M 70.38M 132M 9.19B 134M 909M 354M 4.61B 360M 353M 15.26B P/E 2024 *
-
P/E 2025 -
Enterprise Value 61.18M 71.45M 57.21M 52.38M 98.33M 6.84B 99.6M 676M 264M 3.43B 268M 262M 11.36B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2024-04-10
Director TitleAgeSince
Chairman - 2023-08-10
Director/Board Member - 2024-05-22
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+3.39%+3.50%+25.49% 51.22B
-1.07%+3.69%+479.26%+607.16% 45.38B
+1.44%+5.19%+21.06%+93.98% 41.97B
+1.47%+7.58%+35.29%+21.42% 42.15B
-0.93%-4.80%+17.39%+46.60% 31.95B
-0.60%+2.87% - - 16.73B
+1.32%+6.67%+33.29%+148.62% 17.1B
+0.03%+3.91%+5.84%+35.04% 14.76B
+1.28%+4.95%+84.98%+48.41% 13.91B
Average +0.45%+3.19%+85.08%+128.34% 30.58B
Weighted average by Cap. +0.48%+3.13%+103.29%+150.63%

Financials

2024 2025
Net sales 40.49M 47.28M 37.86M 34.66M 65.07M 4.53B 65.91M 448M 174M 2.27B 178M 174M 7.51B 41.1M 48M 38.43M 35.18M 66.06M 4.59B 66.91M 454M 177M 2.31B 180M 176M 7.63B
Net income 7.15M 8.36M 6.69M 6.12M 11.5M 800M 11.65M 79.09M 30.83M 401M 31.37M 30.68M 1.33B 4.78M 5.58M 4.47M 4.09M 7.69M 535M 7.79M 52.87M 20.61M 268M 20.97M 20.51M 888M
Net Debt -17.25M -20.15M -16.13M -14.77M -27.73M -1.93B -28.09M -191M -74.34M -968M -75.64M -73.99M -3.2B -21.03M -24.56M -19.67M -18.01M -33.81M -2.35B -34.24M -233M -90.63M -1.18B -92.22M -90.21M -3.9B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-